FLASH radiation for skin lymphoma on arms or legs
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This trial is testing a new way of giving radiation therapy (called FLASH) for skin lymphoma. It uses a very fast, low-dose radiation beam to treat the affected area on an arm or leg, which may help reduce side effects. The goal is to see if this approach is safe and tolerable for patients who need palliative (comfort) treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a diagnosis of cutaneous lymphoma (a type of lymphoma that starts in the skin).
- The lymphoma spot must be on an arm or leg and small enough to fit within a circle about 3 inches across.
- You must not have had radiation therapy to that same spot before.
- You must be able to stop using any steroid creams or chemotherapy creams on the treated area for 4 weeks before the radiation starts.
- You must be at least 18 years old and able to give informed consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way of giving radiation therapy for skin cancer, called flash radiotherapy, which may be faster and cause fewer side effects than standard radiation. It is designed for people who are older (60+) and cannot or choose not to have surgery for their skin cancer.
This trial tests a radiation-emitting device placed near the tumor to treat certain malignant skin cancers that can be fully covered. It may help shrink or control the cancer at the skin site where the device is applied.
This trial tests a new type of radiation therapy called ConformalFLASH that delivers radiation extremely quickly to treat head and neck cancer that has come back after previous radiation. It may help patients who cannot have surgery or have declined it.
This trial tests a low-dose radiation treatment to the skin for early-stage mycosis fungoides, a type of lymphoma that affects the skin. The goal is to see if this treatment can help eliminate the cancer cells.
This trial studies a radiation-emitting device (DaRT) to treat certain cancers on the skin, in the mouth, or in superficial soft tissues. You may qualify if you have a confirmed malignant tumor, enough body strength for treatment, and blood tests and pregnancy status that meet safety limits.
This trial tests a special radiation device (DaRT) placed directly into skin cancer tumors. It is designed for patients with weakened immune systems (immunocompromised) who have a single skin cancer lesion on the skin (not spread elsewhere).
Hear when a new Cutaneous Lymphoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.